Top Markets
#1 Black Phoenix Black Phoenix +354.68%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +68.84%
#4 OpenEden OpenEden +62.66%
#5 Akedo Akedo +55.50%
#6 BasedHype BasedHype +26.50%
#7 Cryptopia Cryptopia +21.54%
#8 Avantis Avantis +20.20%
#9 Humanity Humanity +19.73%
#10 Ether.fi Ether.fi +17.74%
Coin of the day
Black Phoenix Black Phoenix
設定
言語
日本
通貨
USD
テーマ
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc

BiVictriX Therapeutics Plc

BVX
株式のランク #40613
BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm... BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm dedicated to pioneering innovative treatments for cancer. The company's core technology involves its distinctive Bi-Cygni therapeutics, which are engineered to precisely identify and combat specific cancer types. Their foremost development program, BVX001, is currently being advanced to address acute myeloid leukaemia. Established in 2016 as BiVictriX Plc, the organization officially adopted its present name, BiVictriX Therapeutics Plc, in August 2021. Its corporate headquarters are located in Macclesfield, United Kingdom.
株価
$0.13607016
最終同期: 2024-09-10
時価総額
$112.29K
変化（1日）
22.46%
変化（1年）
0.00%
国
GB
取引 BiVictriX Therapeutics Plc (BVX)

カテゴリー

Healthcare
BiVictriX Therapeutics Plc（BVX）の株式分割履歴
BiVictriX Therapeutics Plc株（シンボル：BVX）は合計で0回の株式分割を実施しました。
最新の株式分割はAug 13, 2026に行われました。
Aug 13, 2026より前に購入されたBVX株は、現在0BVX株に相当します。
株式分割一覧
年 株式分割 分割比率 累積分割比率
提供された日付のデータは十分ではありません。
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 0 -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0 -
BE